- Home
- Equipment
- asia middle east
- tumor immune
Show results for
Refine by
Tumor Immune Equipment Supplied In Asia Middle East
7 equipment items found
by:Onegene Biotechnology based inSuwon, SOUTH KOREA
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
Manufactured by:Newgen Biotech(Ningbo) Co.,Ltd based inXiangshan County, CHINA
Catering: yogurt, sports and nutrition bars, dietary substitutes, cereals, snacks, baked goods, etc. Beverages: Juices for smoothies, enhanced waters, sports and energy drinks, nutritional drinks, milk and dairy products. Supplements: capsules and tablets, soft candy and chewable tablets, powdered mixture. Pills, effervescent agents, granules, etc. Others: functional food granules, tablet foods, ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Strong scientific and clinical rationale for novel small molecule PD-L1 ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
By hydrolyzing cGAMP (natural ligand of STING) into AMP and GMP, ENPP1 negatively regulates STING-mediated type I interferon production and subsequently prevents innate immune response against tumor. It was suggested that cancer cells acquire immune evasiveness by increasing ENPP1 expression, reflecting over-expression of ENPP1 in many different ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES009 is a potential best-in-class monoclonal antibody targeting LILRB2 designed to reprogram inhibitory myeloid cells to create an immune favorable TME. LILRB2 is an inhibitory receptor that suppresses myeloid cell activation. Blocking LILRB2 reverses immunosuppression by reprograming tumor-associated macrophages (TAMs) from M2 (pro-tumor) to M1 ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Using high-throughput sequencing to test the coding regions and exon-intron junctions of five genes (MLH1, PMS2, MSH2, MSH6, EPCAM) in the germline panel, and the same five genes plus the BRAF V600E mutation in the tissue-based panel. Detection Gene:MMR-related genes MLH1, MSH2, MSH6, PMS2 and EPCAM, BRAF gene V600E mutation. Detection Significance:Germline test as confirmed diagnosis of Lynch ...